K-321 (Ripasudil) for Fuchs Endothelial Corneal Dystrophy (FECD): Emerging Drug Insights and Market Forecasts, 2019-2023 and 2023-2032
January 24, 2024 08:12 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "K-321 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...
ONCOS-102: An Oncolytic Adenovirus with an Immune-Stimulating Transgene - Emerging Drug Analysis and Market Forecasts, 2019-2023 and 2023-2032 with Focus on 7 Major Markets
January 24, 2024 08:11 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "ONCOS-102 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...
PK101 Emerging Drug Insights and Market Forecasts, 2019-2023 and 2023-2032: A NSAID with Increased Effectiveness and Reduced Cardiovascular and Gastrointestinal Side Effects
January 24, 2024 08:10 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "PK101 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. An insightful market forecast...
AMZ001 Emerging Drug Insight and Market Forecasts, 2019-2023 and 2023-2032: A High-strength, Discrete, Odorless, Noninvasive Topical Gel Containing 3.06% Diclofenac Sodium
January 24, 2024 08:09 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "AMZ001 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides a detailed...
SURF-201: 0.2% Betamethasone, A Unique and Potent Corticosteroid - Emerging Drug Insight and Market Forecasts, 2019-2023 and 2023-2032
January 24, 2024 08:08 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "SURF-201 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...
Emerging Fanconi Anemia Treatment RP-L102 Drug Insight and Market Forecasts to 2032
January 24, 2024 08:07 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "RP-L102 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. Industry professionals and...
Emerging Drug Insights and Market Projections for NTCD-M3 in Clostridium Difficile Infection to 2032
January 24, 2024 08:06 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "NTCD-M3 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. Recent analysis of emerging...
AKL4: An Investigational NFkB and Nrf2 Modulator - Emerging Drug Analysis and Market Forecasts, 2019-2023 and 2023-2032 with Focus on United States, Germany, France, Italy, Spain, and United Kingdom
January 24, 2024 08:05 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "AKL4 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...
Sprifermin (AS-902330) Emerging Drug Insights and Market Forecasts, 2019-2023 and 2023-2032: Focus on United States, Germany, France, Italy, Spain, United Kingdom, Canada, and South Korea
January 24, 2024 08:04 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Sprifermin Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides a...
Emerging Drug SDN-037 and Market Forecast to 2032 Highlight Potential Therapeutic Breakthrough in Acute Ocular Pain
January 24, 2024 08:03 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "SDN-037 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. Your source for in-depth...